NCT04026061 is a NA clinical trial of FMA group in Dementia, sponsored by Saxion University of Applied Sciences.

Who is sponsoring NCT04026061?

NCT04026061 is sponsored by Saxion University of Applied Sciences.

What drugs are being tested in NCT04026061?

Interventions in NCT04026061: FMA group, Control group.

What condition does NCT04026061 study?

NCT04026061 studies Dementia, Mobile Applications, Computers, Neurological Rehabilitation, Activities of Daily Living.

Is NCT04026061 still recruiting?

NCT04026061 is currently completed. Last updated 19 July 2019.

Last reviewed 2019-07-19 · How we verify

NCT04026061

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pilot Study Person-centred Tablet Intervention

Completed NA Last updated 19 July 2019

What this trial tests

NA trial testing FMA group in Dementia in 40 participants. Completed in 22 March 2018.

Timeline

31 October 2017

Primary endpoint
12 December 2017

22 March 2018

Quick facts

Lead sponsor	Saxion University of Applied Sciences
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	40
Start date	31 October 2017
Primary completion	12 December 2017
Estimated completion	22 March 2018
Sites	1 location across Netherlands

Drugs / interventions tested

FMA group
Control group — full drug profile →

Conditions studied

Dementia — all drugs for Dementia →
Mobile Applications — all drugs for Mobile Applications →
Computers — all drugs for Computers →
Neurological Rehabilitation — all drugs for Neurological Rehabilitation →

Sponsor

Saxion University of Applied Sciences

Who can join

Eligibility, any sex, with Dementia or Mobile Applications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

First evaluation of FindMyApps, a tablet intervention consisting of a selection tool for usable apps for self-management and meaningful activities and a training that supports informal carers to help people with dementia to learn how to use the tablet and the tool.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dementia

Currently open trials in the same condition.

NCT07531589 — BrainLive Connect: Non-professional Delivered CST for People Living With Dementia · NA · recruiting
NCT07290387 — Tele-Savvy for Latino Caregivers · NA · recruiting
NCT06088810 — The Impact of Music Intervention on Sleep · NA · recruiting
NCT07482800 — Dementia in Fiction and Clinical Narratives · recruiting
NCT07392944 — Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Home · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04026061 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Saxion University of Applied Sciences
Last refreshed: 19 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04026061.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing